CD109 and papilloma: The number and size of papillomas were significantly decreased in CD109−/− mice compared with in CD109+/+ mice; however, we found no significant differences in malignant conversion rate, histological type or invasion/metastasis between CD109+/+ and CD109−/− tumors.